Stay updated on PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.

Latest updates to the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe version history now shows the current release as Revision: v3.6.6, replacing the previous Revision: v3.6.5 in the history.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page footer now shows Revision: v3.6.5, replacing Revision: v3.6.4. This reflects a software version update rather than changes to study data or page content.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new build/version of the study history page.SummaryDifference0.0%

- Check66 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the study history, replacing the previous 'Revision: v3.6.2'. This reflects an updated platform release recorded in the version history.SummaryDifference0.0%

- Check80 days agoChange DetectedA new history entry was added for 2026-06-26 indicating a Study Status update with version 142 and Revision: v3.6.2, and an earlier 2026-02-20 entry as well as Revision: v3.6.0 were removed.SummaryDifference0.1%

- Check94 days agoChange DetectedThe record now shows that the study is not enrolling participants, and the history includes a new revision (v3.6.0) replacing the prior revision (v3.5.5).SummaryDifference0.1%

Stay in the know with updates to PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Coformulation vs Pembrolizumab Clinical Trial page.